10-day Decitabine, Fludarabine and 2 Gray TBI as Conditioning Strategy for Poor and Very Poor Risk AML in CR1

Name: 10-day Decitabine, Fludarabine and 2 Gray TBI as Conditioning Strategy for Poor and Very Poor Risk AML in CR1
Published: 2014
License: Public Domain

Radboud University Medical Center · 2014

ClinicalTrials.gov · Datasets · License: Public Domain · 2014

Open Source ↗

acute myeloid leukemia (aml), decitabine, hematopoietic stem cell transplantation (hsct), conditioning, aml, interventional, phase2

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

10-day Decitabine, Fludarabine and 2 Gray TBI as Conditioning Strategy for Poor and Very Poor Risk AML in CR1

Related documents